January 23, 2014—The federal government and drugmakers have made their final arguments in the industry's lawsuit over the government regulation that lets certain rural and cancer hospitals access 340B discounts on orphan drugs when used for non-orphan indications. … [Read more...]
Congress Agrees to More than Double 340B Program Funding
OPA would be expected to implement long-delayed requirementsJanuary 14, 2014—House and Senate negotiators have signed off on a federal spending bill for the fiscal year that runs through September that would more than double the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs' (OPA) budget, including $6 million for new 340B program integrity efforts. … [Read more...]
Government Asks Court to Uphold 340B Orphan Drug Rule
PhRMA expected to make its final arguments by the end of this weekJanuary 14, 2014—If the federal government's legal defense of the 340B orphan drug regulation is successful, it might have to send Sherlock Holmes a thank-you note. … [Read more...]
Will 2014 Be the Year of the 340B Mega-Reg?
A rundown of what's in store for 340B in the coming yearJanuary 10, 2014—With just one exception, the federal government has always managed the 340B program without formal regulations, setting 340B's rules of the road instead through guidelines, policy releases, FAQs, and the like. … [Read more...]
The True Number of 340B Contract Pharmacies
Perhaps the most misreported number in the 340B debate is the number of pharmacies that have contracts with 340B healthcare providers. That number currently stands at 13,833. Not 41,051. The confusion comes from the way the Office of Pharmacy Affairs tracks contract pharmacies in its database. Instead of listing these brick-and-mortar stores only once, the agency counts the … [Read more...]
HRSA Issues Last Two 340B Provider Audit Summaries for 2012
Plans to use results to develop best practicesJanuary 10, 2014—The Health Resources and Services Administration (HRSA) yesterday released the remaining two summaries of the 51 audits of 340B covered entities it performed in fiscal year 2012. HRSA's latest update also includes brief descriptions of how some audits were resolved. Many of the audits are still not final, however. … [Read more...]
340B Drug Purchases Are Just Shy of $7 Billion Annually
HRSA supplies figure in a filing in orphan drug exclusion lawsuitJanuary 9, 2014—The dollar amount of pharmaceuticals purchased through the 340B program has been a guesstimate—until now. … [Read more...]